Chantix (varenicline)

Chantix (varenicline) is a prescription medication used to treat smoking addiction

Chantix is a prescription medication used to treat smoking addiction. Chantix was approved in May of 2006 in the U.S. as an aid to smoking cessation. It has been prescribed to more than 4 million patients in the United States since its approval. Chantix is the first non-nicotine prescription treatment for smoking cessation in almost a decade.

Chantix, is a selective nicotinic acetylcholine receptor partial agonist. As a partial agonist, it both reduces cravings for and decreases the pleasurable effects of cigarettes and other tobacco products, and through these mechanisms, it can assist some patients in stopping smoking.

Do you have a Chantix claim?

If your loved one has suffered a serious injury or death as a result of a side effect of Chantix, you may be entitled to compensation for medical expenses, loss of wages, and pain and suffering.

Please contact our Chantix lawyers today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost, no-obligation legal evaluation of your case.

Latest News

Are Chantix reactions a laughing matter?

The number of bloggers out there writing about their personal experiences with Chantix and documenting, for the world to see, the musings of a mind tortured by nicotine withdrawal, seems to be proliferating even as prescriptions for the smoking cessation drug decline. Now it appears that a new genre in world of Chantix information has emerged: the Comical Side Effect.

Read the rest of this entry »

Chantix plays role in record number of drug reactions

According to The Institute for Safe Medicine Practices (ISMP), the number of drug-related adverse events and deaths reported to the Food and Drug Administration has hit a record level. Numbers pulled from the FDA’s Adverse Event Reporting System (AERS) reveal that Heparin and Chantix are largely to blame for the upward swing.

Read the rest of this entry »

Researchers recommend new Chantix warnings

Researchers at the Institute for Safe Medicine Practices, a nonprofit organization, and Wake Forest University say that their latest review of Chantix data justifies stepping up warnings about the drug.

More than 1,000 complications were reported in the first quarter of 2008, including 15 traffic accidents, 52 incidents of loss of consciousness and blackouts, and 50 deaths.

Reports of adverse effects among users taking Chantix were greater than any other prescription drug for the second quarter in a row.

Read the rest of this entry »